FRED ALGER MANAGEMENT, LLC

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 3520 NEW YORK, NY

Position in DNTH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$126,967,017

+$29,458,439 QoQ

Shares Held

1,302,493

+12.1% QoQ

Ownership

2.33%

of shares outstanding

% of Portfolio

0.42%

of 13F equity value

Holder Rank

#12

of 267 holders

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

FRED ALGER MANAGEMENT, LLC holds $748,337,711 across 53 Biotechnology names. DNTH ranks #2 (17.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARWR	Arrowhead Pharmaceuticals, Inc.	3,301,919	$269,139,417
2	DNTH	Dianthus Therapeutics, Inc. /DE/ This page	1,302,493	$126,967,017
3	RVMD	Revolution Medicines, Inc.	259,468	$48,593,167
4	ASND	Ascendis Pharma A/S	171,447	$45,728,343
5	COGT	Cogent Biosciences, Inc.	1,072,830	$41,518,521
6	ROIV	Roivant Sciences Ltd.	1,081,421	$38,271,489
7	FBRX	Forte Biosciences, Inc.	1,439,697	$30,593,561
8	ERAS	Erasca, Inc.	1,308,455	$23,970,895

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$126,967,017	1,302,493	+12.1%	Shares	Sole	2026-08-14
2026-03-31	$97,508,578	1,161,923	+3372.6%	Shares	Sole	2026-05-15
2025-12-31	$1,378,886	33,460	-26.1%	Shares	Sole	2026-02-17
2025-09-30	$1,782,712	45,304	+370.3%	Shares	Sole	2025-11-14
2024-09-30	$263,751	9,633	+52.5%	Shares	Sole	2024-11-14
2024-06-30	$163,483	6,317	-82.6%	Shares	Sole	2024-08-14
2024-03-31	$1,091,010	36,367	-11.0%	Shares	Sole	2024-05-15
2023-12-31	$424,746	40,841	—	Shares	Sole	2024-02-14
2021-03-31 MGTA	—	79,507	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.